Stoke Therapeutics, Inc.
STOK
$19.56
-$0.12-0.61%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 199.89M | 190.91M | 36.56M | 16.74M | 15.16M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 199.89M | 190.91M | 36.56M | 16.74M | 15.16M |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 199.89M | 190.91M | 36.56M | 16.74M | 15.16M |
SG&A Expenses | 55.45M | 53.23M | 48.79M | 46.56M | 44.14M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 159.61M | 152.67M | 137.93M | 134.05M | 129.69M |
Operating Income | 40.28M | 38.24M | -101.37M | -117.30M | -114.53M |
Income Before Tax | 53.76M | 51.55M | -88.98M | -105.46M | -103.57M |
Income Tax Expenses | 1.28M | 1.28M | -- | -- | -- |
Earnings from Continuing Operations | 52.48 | 50.27 | -88.98 | -105.46 | -103.57 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 52.48M | 50.27M | -88.98M | -105.46M | -103.57M |
EBIT | 40.28M | 38.24M | -101.37M | -117.30M | -114.53M |
EBITDA | 42.27M | 40.33M | -99.19M | -115.03M | -112.16M |
EPS Basic | 0.90 | 0.84 | -1.68 | -2.10 | -2.19 |
Normalized Basic EPS | 0.57 | 0.54 | -1.05 | -1.31 | -1.37 |
EPS Diluted | 0.84 | 0.79 | -1.68 | -2.10 | -2.19 |
Normalized Diluted EPS | 0.54 | 0.51 | -1.05 | -1.31 | -1.37 |
Average Basic Shares Outstanding | 229.59M | 227.00M | 215.38M | 203.31M | 191.24M |
Average Diluted Shares Outstanding | 231.12M | 228.53M | 215.38M | 203.31M | 191.24M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |